Amir Mortazavi, MD

Amir Mortazavi

College

College of Medicine

Department/Division

Internal Medicine

Academic Title

Professor

Research Program

Molecular Carcinogenesis and Chemoprevention

Research Interest

Cancer, Urinary Bladder Cancer, Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Weight Loss, Colorectal Cancer, Carcinoma, Renal Cell, Anorexia, Leukemia, Promyelocytic, Acute

Amir Mortazavi, MD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on epigenetic modifications and experimental therapeutics for genitourinary cancers.

One of his recent research projects suggests that sorafenib, an oral multikinase inhibitor, could have off-target effects on cytokine-induced signal transduction in immune effector cells.

Dr. Mortazavi has co-authored many articles in well-respected publications, including Cancer Chemotherapy and Pharmacology, Journal of Immunology, Journal of Proteome Research and Journal of Magnetic Resonance Imaging.


Office Location

A441 Starling Loving Hall

320 W 10th Ave, Columbus, OH 43210


614-293-2886

614-293-7525



Publications

Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Search for Clinical Trials

Find a Scientific Publication